CCR5 and HIV-1 infection: The feasibility of curing HIV-1 infection was first demonstrated in the Berlin and London patients, who achieved sustained viral remission through C—C chemokine receptor type 5 (CCR5)-Δ32 homozygous hematopoietic stem cell transplantation (HSCT) while being treated for hematologic malignancies.